# EDGAR Filing Document

**Accession Number:** 0000102037
**File Stem:** 0000102037-23-000013
**Filing Date:** 2023-3
**Character Count:** 14354
**Document Hash:** 063fd58bcd0f53f725e603db2725dde7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000102037-23-000013.hdr.sgml**: 20230508

**ACCESSION NUMBER**: 0000102037-23-000013

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20230331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UNIVERSAL CORP /VA/
- **CENTRAL INDEX KEY:** 0000102037
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-FARM PRODUCT RAW MATERIALS [5150]
- **IRS NUMBER:** 540414210
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 9201 FOREST HILL AVENUE
- **STREET 2:** STONY POINT II BUILDING
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235
- **BUSINESS PHONE:** 8043599311

**MAIL ADDRESS:**
- **STREET 1:** 9201 FOREST HILL AVENUE
- **STREET 2:** STONY POINT II BUILDING
- **CITY:** RICHMOND
- **STATE:** VA
- **ZIP:** 23235

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** UNIVERSAL LEAF TOBACCO CO INC
- **DATE OF NAME CHANGE:** 19880314

![imagea.jpg](imagea.jpg)

March 31, 2023

**<u>Via Email and</u>**

**<u>EDGAR Transmission</u>**

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 3561

Washington, D.C. 20549

Attention:&nbsp;&nbsp;&nbsp;&nbsp;Ms. Suying Li

Office of Trade & Services

**Re:&nbsp;&nbsp;&nbsp;&nbsp;Universal Corporation**

**Form 10-K for Fiscal Year Ended March 31, 2022**

**Filed May 27, 2022**

**File No. 001-00652**

Dear Ms. Li,

As Senior Vice President and Chief Financial Officer of Universal Corporation, a Virginia corporation (the "Company"), I am transmitting herewith for filing the Company's response to the comments of the staff (the "Staff') of the Division of Corporation Finance of the Securities and Exchange Commission (the "Commission") contained in its comment letter dated March 13, 2023 (the "Commission Comment Letter"). We appreciate your agreement on March 21, 2023, to extend the due date for the Company's response to April 7, 2023.

Set forth below are the Company's responses. For ease of reference, the Staff comments are reprinted in italics, numbered to correspond with the paragraph numbers assigned in the Commission Comment Letter, and are followed by the corresponding responses of the Company. When used in our responses, the "Company," "we," "us," and "our" refer to Universal Corporation.

<u>Form 10-K for Fiscal Year Ended March 31, 2022</u>

<u>Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations</u>

<u>Financial Highlights</u>

<u>Reconciliation of Certain Non-GAAP Financial Measures</u>

<u>Adjusted Net Income and Diluted Earnings Per Share Reconciliation, page 29</u>

*1. Please revise your reconciliation to separately present the income tax effects related to the non-GAAP adjustments and provide an explanation of how the tax impacts are determined. Refer to Question 102.11 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations.*

**Response:** 

The Company acknowledges the Staff's comment and in future filings will quantify the total income tax impact for the non-GAAP adjustments to income before income taxes in a single line item on the Adjusted Net Income Reconciliation. Additionally, the Company will provide explanation and clarification of how the income tax expense (benefit) on non-GAAP adjustments is determined in the parenthetical footnotes to the Adjusted Net Income Reconciliation.

------

U.S. Securities & Exchange Commission

March 31, 2023

Below is a presentation of the Adjusted Net Income and Adjusted Diluted Earnings Per Share Reconciliation for fiscal years ended March 31, 2022, and 2021 reflecting these changes:

---

| | | |
|:---|:---|:---|
| **Adjusted Net Income and Adjusted Diluted Earnings Per Share Reconciliation** | | |
| | **Fiscal Year Ended <br>March 31,** | **Fiscal Year Ended <br>March 31,** |
| *(in thousands except for per share amounts)* | **2022** | **2021** |
| As Reported: Net income attributable to Universal Corporation | $86577 | $87410 |
| Non-GAAP adjustments to income before income taxes |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase accounting adjustment<sup>(1)</sup> | 3057 | 2800 |
| &nbsp;&nbsp;&nbsp;&nbsp;Transaction costs for acquisitions<sup>(2)</sup> | 2310 | 3915 |
| &nbsp;&nbsp;&nbsp;&nbsp;Fair value adjustment to contingent consideration for FruitSmart acquisition<sup>(3)</sup> | (2532) | (4173) |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and impairment costs<sup>(4)</sup> | 10457 | 22577 |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest (income) expense related to a final income tax ruling and settlements at a foreign subsidiary | (470) | 1849 |
| Total of Non-GAAP adjustments to income before income taxes | 12822 | 26968 |
| Non-GAAP adjustments to income taxes |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Impact to income taxes (benefit) from Non-GAAP adjustments to income before income taxes<sup>(5)</sup> | (2181) | (4290) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax benefit on a final tax ruling (fiscal year 2022) and dividends paid from foreign subsidiaries (fiscal year 2021)<sup>(6)</sup> | (1686) | (4421) |
| Total of income tax impacts for Non-GAAP adjustments to income before income taxes and Non-GAAP adjustments to income taxes | (3867) | (8711) |
| Impact to net income attributable to noncontrolling interests in subsidiaries from Non-GAAP adjustments | (1154) | (487) |
| As adjusted: Net income attributable to Universal Corporation (Non-GAAP) | $94378 | $105180 |
| As reported: Diluted earnings per share | $3.47 | $3.53 |
| As adjusted: Diluted earnings per share (Non-GAAP) | $3.79 | $4.25 |

---

<sup>(1)</sup> The Company recognized an increase in cost of goods sold in the third quarters of fiscal year 2022 and 2021, relating to the expensing of fair value adjustments to inventory associated with the acquisition accounting for Shank's (effective October 4, 2021) and Silva (effective October 1, 2020). The adjustment related to the Silva acquisition is not deductible for U.S. income tax purposes.

<sup>(2)</sup> The Company incurred selling, general, and administrative expenses for the due diligence and other transaction costs associated with the acquisitions of Shank's and Silva. A portion of the transaction costs associated with the Shank's acquisition are not deductible for U.S. income tax purposes. The transaction costs for the Silva acquisition are not deductible for U.S. income tax purposes.

<sup>(3)</sup> The Company reversed the contingent consideration liability for the FruitSmart acquisition, as a result of certain performance metrics that did not meet the required threshold stipulated in the purchase agreement.

<sup>(4)</sup> Restructuring and impairment costs are included in Consolidated operating income in the consolidated statements of income, but excluded for purposes of Adjusted operating income, Adjusted net income available to Universal Corporation, and Adjusted diluted earnings per share. See Note 4 for additional information.

<sup>(5)</sup> The income tax effect of Non-GAAP adjustments was determined based on the timing and nature of the specific Non-GAAP adjustments and their relevant jurisdictional income tax rates (foreign, state, and local) and the applicable U.S. federal income tax rates. The Company considers current and deferred income tax rates to calculate the impact to income taxes for the Non-GAAP adjustments.

<sup>(6)</sup> The Company recognized income tax benefits related to a favorable final income tax ruling at a foreign subsidiary (fiscal year 2022) and final U.S. tax regulations on certain dividends paid by foreign subsidiaries (fiscal year 2021).

<u>Item 8. Financial Statements and Supplementary Data</u>

<u>Consolidated Balance Sheets, page 45</u>

*2. Please present accounts payable separately from accrued expenses. Also, tell us and disclose with quantification as of each balance sheet date any component of accrued expenses exceeding the disclosure threshold. Refer to Rules 5-02.19 and .20 of Regulation S-X.*

**Response:** 

The Company acknowledges the Staff's comment and respectfully advises the Staff that for the fiscal years ended March 31, 2022 and 2021, accounts payable represented $168.5 million and $61.8 million, respectively. For the fiscal years ended March 31, 2022 and 2021, the combined balance of accrued expenses and other current liabilities represented $103.6 million and $77.7 million, respectively. Dividends payable on outstanding common

------

U.S. Securities & Exchange Commission

March 31, 2023

stock, a component of other current liabilities, represented $18.9 million or 6.4% of total current liabilities on the consolidated balance sheet for the fiscal year ended March 31, 2021. Although the balance of dividends payable at March 31, 2021 exceeded the 5% threshold as defined by Rule 5-02.20 of Regulation S-X, we believed the amount was not material to disclose on the consolidated balance sheet. No other components of accrued expenses and other current liabilities exceeded 5% of total current liabilities for the fiscal years ended March 31, 2022 or 2021.

The following table separately presents the Total current liabilities section for the respective consolidated balance sheets filed on Form 10-K for fiscal years ended March 31, 2022 and 2021:

---

| | | |
|:---|:---|:---|
| | **March 31,** | **March 31,** |
| **(in thousands of dollars)** | 2022 | 2021 |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Notes payable and overdrafts | $182639 | $101294 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 168491 | 61827 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable - unconsolidated affiliates | 5308 | 1282 |
| &nbsp;&nbsp;&nbsp;&nbsp;Customer advances and deposits | 13724 | 8765 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued compensation | 27281 | 29918 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes payable | 7427 | 4516 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of operating lease liabilities | 10303 | 7898 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 103551 | 77657 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of long-term debt |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 518724 | 293157 |

---

In future filings, we will separately present accounts payable and accrued expenses and other current liabilities on our consolidated balance sheets. Additionally, in future filings, we will quantify and determine if any amounts exceed the 5% threshold and will disclose the amount(s), if material, on the consolidated balance sheets or in the notes to the consolidated financial statements.

<u>Consolidated Statements of Cash Flows, page 47</u>

*3. Please breakout the line items under the changes in operating assets and liabilities, net section of your cash flows from operating activities into smaller components. For example, changes in inventories should be presented separately from other assets. Refer to ASC 230-10-45-29.*

**Response:** 

The Company acknowledges the Staff's comment and in future filings will expand the number of line items presented in the changes in operating assets and liabilities section of the operating activities category on the consolidated statements of cash flows.

------

U.S. Securities & Exchange Commission

March 31, 2023

Below is a presentation of the operating activities section of the consolidated statements of cash flows for the fiscal years ended March 31, 2022, 2021, and 2020 reflecting this change:

---

| | | | |
|:---|:---|:---|:---|
| | Fiscal Year Ended March 31, | Fiscal Year Ended March 31, | Fiscal Year Ended March 31, |
| **(in thousands of dollars)** | 2022 | 2021 | 2020 |
| **Cash Flows From Operating Activities** |  |  |  |
| Net income | $103604 | $96314 | $78003 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 52521 | 44733 | 38379 |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for losses (recoveries) on advances and guaranteed loans to suppliers | 5988 | 5534 | 937 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventory writedowns | 19944 | 13463 | 10319 |
| &nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 6186 | 6106 | 5631 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency remeasurement loss (gain), net | 19029 | (8475) | 16422 |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency exchange contracts | (13210) | (1567) | 499 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (2473) | (2335) | (8697) |
| &nbsp;&nbsp;&nbsp;&nbsp;Equity in net (income) loss of unconsolidated affiliates, net of dividends | (329) | (296) | 1101 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring and impairment costs | 10457 | 22577 | 7543 |
| &nbsp;&nbsp;&nbsp;&nbsp;Restructuring payments | (4134) | (8283) | (2787) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in estimated fair value of contingent consideration for FruitSmart acquisition | (2532) | (4173) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Other, net | 513 | (1373) | (9271) |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in operating assets and liabilities, net: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable and advances from suppliers | (23185) | (5239) | 16267 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (245920) | 54553 | (99094) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | (15991) | (11354) | 4556 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | 108746 | 11331 | (22673) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other current liabilities | 14356 | 14840 | (25861) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income taxes | 6644 | (4516) | 10927 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Customer advances and deposits | 4668 | (1426) | (11304) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash provided by operating activities | 44882 | 220414 | 10897 |

---

\*\*\*\*\*\*\*\*\*\*\*\*\*\*

We believe the foregoing answers are responsive to your comments. Should the Staff have further questions or comments regarding the foregoing, please do not hesitate to contact the undersigned at (804) 359-9311.

Sincerely,

<u>/s/ Johan Kroner</u> 

Johan Kroner

Senior Vice President and

Chief Financial Officer

<br>